Colon cancer is on the rise in young people – so should the under-55s pay for a colonoscopy?
If there’s one person who helped shake the stigma of bowel cancer in the young, it was the late Dame Deborah James. The ...
Le Lézard1 天
Pfizer's BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with ...
Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...